TET2 mutation order also influences disease biology in MPN, where TET2 arising prior to JAK2V617F favoured an ET phenotype and TET2 as a secondary mutation following JAK2V617F favoured a PV phenotype [123]. Here, TET2 is linked to myeloproliferative neoplasm.